JP2020522471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020522471A5 JP2020522471A5 JP2019564131A JP2019564131A JP2020522471A5 JP 2020522471 A5 JP2020522471 A5 JP 2020522471A5 JP 2019564131 A JP2019564131 A JP 2019564131A JP 2019564131 A JP2019564131 A JP 2019564131A JP 2020522471 A5 JP2020522471 A5 JP 2020522471A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- clostridium
- porcine
- use according
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 28
- 230000002163 immunogen Effects 0.000 claims 25
- 241000193163 Clostridioides difficile Species 0.000 claims 14
- 229960005486 vaccine Drugs 0.000 claims 12
- 241000700605 Viruses Species 0.000 claims 10
- 239000003053 toxin Substances 0.000 claims 10
- 231100000765 toxin Toxicity 0.000 claims 10
- 108700012359 toxins Proteins 0.000 claims 10
- 241000193468 Clostridium perfringens Species 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 244000144972 livestock Species 0.000 claims 6
- 241000711573 Coronaviridae Species 0.000 claims 4
- 208000005577 Gastroenteritis Diseases 0.000 claims 4
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 claims 4
- 206010037660 Pyrexia Diseases 0.000 claims 4
- 241000960387 Torque teno virus Species 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 230000002458 infectious effect Effects 0.000 claims 4
- 230000008774 maternal effect Effects 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 208000011580 syndromic disease Diseases 0.000 claims 4
- 241000193403 Clostridium Species 0.000 claims 3
- 241001465754 Metazoa Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- 230000036039 immunity Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 241000588807 Bordetella Species 0.000 claims 2
- 241000589968 Borrelia Species 0.000 claims 2
- 241001148534 Brachyspira Species 0.000 claims 2
- 241000589562 Brucella Species 0.000 claims 2
- 241000589876 Campylobacter Species 0.000 claims 2
- 241000606161 Chlamydia Species 0.000 claims 2
- 241000194033 Enterococcus Species 0.000 claims 2
- 241000588722 Escherichia Species 0.000 claims 2
- 108010092442 Escherichia coli Adhesins Proteins 0.000 claims 2
- 241000589989 Helicobacter Species 0.000 claims 2
- 206010022678 Intestinal infections Diseases 0.000 claims 2
- 241000567229 Isospora Species 0.000 claims 2
- 241001469654 Lawsonia <weevil> Species 0.000 claims 2
- 241000186781 Listeria Species 0.000 claims 2
- 208000016604 Lyme disease Diseases 0.000 claims 2
- 241000204031 Mycoplasma Species 0.000 claims 2
- 241000202347 Porcine circovirus Species 0.000 claims 2
- 241000702619 Porcine parvovirus Species 0.000 claims 2
- 241000589516 Pseudomonas Species 0.000 claims 2
- 241000702670 Rotavirus Species 0.000 claims 2
- 241000607142 Salmonella Species 0.000 claims 2
- 241000191940 Staphylococcus Species 0.000 claims 2
- 241000194017 Streptococcus Species 0.000 claims 2
- 241000589886 Treponema Species 0.000 claims 2
- 241000607598 Vibrio Species 0.000 claims 2
- 239000000443 aerosol Substances 0.000 claims 2
- 230000007812 deficiency Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 201000002491 encephalomyelitis Diseases 0.000 claims 2
- 208000028774 intestinal disease Diseases 0.000 claims 2
- 244000005700 microbiome Species 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 238000002255 vaccination Methods 0.000 claims 2
- 239000002776 alpha toxin Substances 0.000 claims 1
- 230000001886 ciliary effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000037902 enteropathy Diseases 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023076996A JP2023113631A (ja) | 2017-06-09 | 2023-05-09 | クロストリジウム類毒素を含むワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382358 | 2017-06-09 | ||
| EP17382358.4 | 2017-06-09 | ||
| PCT/EP2018/065025 WO2018224595A1 (en) | 2017-06-09 | 2018-06-07 | Vaccine comprising clostridium toxoids |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023076996A Division JP2023113631A (ja) | 2017-06-09 | 2023-05-09 | クロストリジウム類毒素を含むワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020522471A JP2020522471A (ja) | 2020-07-30 |
| JP2020522471A5 true JP2020522471A5 (enExample) | 2021-07-26 |
| JP7349366B2 JP7349366B2 (ja) | 2023-09-22 |
Family
ID=59078007
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019564131A Active JP7349366B2 (ja) | 2017-06-09 | 2018-06-07 | クロストリジウム類毒素を含むワクチン |
| JP2023076996A Withdrawn JP2023113631A (ja) | 2017-06-09 | 2023-05-09 | クロストリジウム類毒素を含むワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023076996A Withdrawn JP2023113631A (ja) | 2017-06-09 | 2023-05-09 | クロストリジウム類毒素を含むワクチン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11154605B2 (enExample) |
| EP (1) | EP3634480A1 (enExample) |
| JP (2) | JP7349366B2 (enExample) |
| BR (1) | BR112019024412A2 (enExample) |
| CA (1) | CA3064357A1 (enExample) |
| MX (1) | MX388528B (enExample) |
| WO (1) | WO2018224595A1 (enExample) |
| ZA (1) | ZA201907715B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202509058A (zh) * | 2023-08-24 | 2025-03-01 | 法商西華動物藥品股份有限公司 | 抗豬感染之多價疫苗 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY149604A (en) | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
| AR089797A1 (es) | 2012-01-27 | 2014-09-17 | Merck Sharp & Dohme | Vacunas contra clostridum difficile que comprenden toxinas recombinantes |
| US20160045586A1 (en) | 2013-03-15 | 2016-02-18 | Sanofi Pasteur, Inc. | Toxoid, Compositions and Related Methods |
-
2018
- 2018-06-07 JP JP2019564131A patent/JP7349366B2/ja active Active
- 2018-06-07 WO PCT/EP2018/065025 patent/WO2018224595A1/en not_active Ceased
- 2018-06-07 EP EP18731386.1A patent/EP3634480A1/en active Pending
- 2018-06-07 BR BR112019024412-3A patent/BR112019024412A2/pt unknown
- 2018-06-07 US US16/620,846 patent/US11154605B2/en active Active
- 2018-06-07 MX MX2019013779A patent/MX388528B/es unknown
- 2018-06-07 CA CA3064357A patent/CA3064357A1/en active Pending
-
2019
- 2019-11-21 ZA ZA2019/07715A patent/ZA201907715B/en unknown
-
2023
- 2023-05-09 JP JP2023076996A patent/JP2023113631A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015512449A5 (enExample) | ||
| JP2016531854A5 (enExample) | ||
| CA2977980C (en) | Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom | |
| Jiao et al. | Comparative study of the effects of aluminum adjuvants and Freund's incomplete adjuvant on the immune response to an Edwardsiella tarda major antigen | |
| JP2015512448A5 (enExample) | ||
| ES2349041T3 (es) | Derivados de hidantoina para el tratamiento de trastornos inflamatorios. | |
| TWI458491B (zh) | 藉由ｐｃｖ２抗原減少豬隻之伴隨感染 | |
| JP5041445B2 (ja) | マイコプラズマｐｒｒｓｖに対するワクチン | |
| KR102632419B1 (ko) | 돼지용 조합 백신 | |
| RU2013114405A (ru) | Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций | |
| RU2016110430A (ru) | Pcv2b дивергентная вакцинная композиция и способы её применения | |
| JP2012524548A5 (enExample) | ||
| TW200927166A (en) | Mycoplasma hyopneumoniae avirulent-adjuvanted live vaccine | |
| Arshadi et al. | Immunogenic potency of formalin and heat inactivated E. coli O157: H7 in mouse model administered by different routes | |
| JP2020522471A5 (enExample) | ||
| JP2019509300A5 (enExample) | ||
| RU2018137034A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| BR112020012483A2 (pt) | vacina de combinação intradérmica contra mycoplasma e circovírus porcino | |
| JP2009514840A5 (enExample) | ||
| Li et al. | Development and efficacy of a novel streptomycin-resistant Flavobacterium johnsoniae vaccine in grass carp (Ctenopharyngodon idella) | |
| CN101420975B (zh) | 抗支原体和prrsv的疫苗 | |
| Sánchez-Jiménez et al. | Distribution of pathogenicity islands among Colombian isolates of Salmonella | |
| CN100336823C (zh) | 一种鸡特异性的CpG ODN及其应用 | |
| Xu et al. | Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera | |
| JP2023113631A (ja) | クロストリジウム類毒素を含むワクチン |